Dose-volume correlates of the prevalence of patient-reported trismus in long-term survivorship after oropharyngeal IMRT: a cross-sectional dosimetric analysis

Survivors of oropharyngeal carcinoma (OPC) treated with radiotherapy (RT) risk a host of substantial, lifelong functional impairments. Functional toxicity is of particular interest in OPC survivorship as the rise in biologically favorable HPV-associated disease in younger patients has led to unprecedented numbers of long-term survivors facing late effects of RT at relatively young ages (commonly in their 60s). Thus, it is more imperative than ever to develop and implement proactive risk reduction strategies in these patients to minimize or prevent loss of function and improve quality of life (QOL) after RT [1].

Source: Radiotherapy and Oncology - May 4, 2020 Category: Radiology Authors: Mona Kamal, Crosby Rock, Stephen Grant, Jhankruti Zaveri, Robin Claire Granberry, Barrett O'Donnell, Amy Dursteler, Benjamin W. Warren, Stefania Volpe, Karine Al Feghali, Carlos E. Cardenas, Richard Cardoso, Stephen Lai, Abdallah Sherif Radwan, Clifton D. Tags: Original Article Source Type: research